Immunophenotypic abnormality quantification refines multiparameter flow cytometry‐based measurable residual disease testing in adults allografted for acute myeloid leukemia in morphologic remission

Documenti analoghi

• Inflammatory signaling in the pathogenesis of acute myeloid leukemia
  di: Artemis Margrith Baumann, et al.
  Pubblicazione: (2025)
• HLA diversity is associated with TKI response and treatment‐free remission in chronic myeloid leukemia
  di: Charles Toulemonde, et al.
  Pubblicazione: (2025)
• Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study
  di: André Baruchel, et al.
  Pubblicazione: (2025)
• Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute myeloid leukemia
  di: Francesco Leonetti, et al.
  Pubblicazione: (2025)
• Cell surface surprise: NPM1 is an immune therapy target for acute myeloid leukemia
  di: Hansen J. Kosasih, et al.
  Pubblicazione: (2025)